Latest news with #Aleve
Yahoo
17-04-2025
- Business
- Yahoo
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
The facility's new space enhances the company's Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa., April 16, 2025--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community. The ribbon-cutting ceremony was attended by Bayer leaders, employees, elected officials, and members of the local community to commemorate this exciting moment for Bayer and Pennsylvania's Lebanon County. Bayer's Myerstown site has a rich history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer's Consumer Health network globally, producing brands such as Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, Midol®, and more. "Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before," stated Dave Tomasi, President of Bayer's Consumer Health division in North America. "The expanded facility will further strengthen our commitment to providing safe, effective and high-quality self-care solutions that our consumers and customers can depend on." Bayer's Myerstown facility is set to advance its production capabilities through the integration of modernized technology and streamlined processes, strengthening its ability to reliably deliver science-driven self-care solutions. The new space is designed to move products more efficiently with eight new product packaging lines and automated systems in logistics. With the expansion, Bayer is increasing its ability to swiftly respond to the evolving needs of its consumers and customers. Bayer's commitment to growth extends beyond infrastructure and technology; it is an investment in the future of health and wellness for consumers across North America and the people of Myerstown. Along with expanding its physical footprint, the company is dedicated to digitally upskilling its workforce to ensure that employees and the local community are equipped with the knowledge needed to navigate the modern manufacturing landscape. Bayer also plans to welcome local high school educators to tour its Myerstown facilities and operations to bring back information and insights to their school districts. "We recognize that the key to sustainable growth lies in our people. That's why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers," said Divakar Amin, Vice President & Site Manager of Myerstown. "We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals. Together, we are building a brighter future for Bayer and the communities we serve." As Bayer continues to innovate and empower everyday health, the company remains steadfast in its mission to elevate the quality of life for people around the world through trusted health and nutrition solutions. "Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none," said Michael Sullivan, Senior Vice President of Product Supply for Bayer's Consumer Health division in North America. "We are excited about the positive impact this investment will have as we are paving the way for a healthier future where everyone has access to the products that they need to support their well-being." About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to View source version on Contacts Media Contact: Hannah SchwartzEmail: Cell: 862-783-8442 Sign in to access your portfolio
Yahoo
16-04-2025
- Business
- Yahoo
Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community
The facility's new space enhances the company's Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa., April 16, 2025--(BUSINESS WIRE)--Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to Bayer's commitment to providing trusted self-care solutions to consumers across North America while advancing meaningful engagement with the local community. The ribbon-cutting ceremony was attended by Bayer leaders, employees, elected officials, and members of the local community to commemorate this exciting moment for Bayer and Pennsylvania's Lebanon County. Bayer's Myerstown site has a rich history dating back over 75 years, and it has now grown to become the largest manufacturing site in Bayer's Consumer Health network globally, producing brands such as Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, Midol®, and more. "Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before," stated Dave Tomasi, President of Bayer's Consumer Health division in North America. "The expanded facility will further strengthen our commitment to providing safe, effective and high-quality self-care solutions that our consumers and customers can depend on." Bayer's Myerstown facility is set to advance its production capabilities through the integration of modernized technology and streamlined processes, strengthening its ability to reliably deliver science-driven self-care solutions. The new space is designed to move products more efficiently with eight new product packaging lines and automated systems in logistics. With the expansion, Bayer is increasing its ability to swiftly respond to the evolving needs of its consumers and customers. Bayer's commitment to growth extends beyond infrastructure and technology; it is an investment in the future of health and wellness for consumers across North America and the people of Myerstown. Along with expanding its physical footprint, the company is dedicated to digitally upskilling its workforce to ensure that employees and the local community are equipped with the knowledge needed to navigate the modern manufacturing landscape. Bayer also plans to welcome local high school educators to tour its Myerstown facilities and operations to bring back information and insights to their school districts. "We recognize that the key to sustainable growth lies in our people. That's why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers," said Divakar Amin, Vice President & Site Manager of Myerstown. "We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals. Together, we are building a brighter future for Bayer and the communities we serve." As Bayer continues to innovate and empower everyday health, the company remains steadfast in its mission to elevate the quality of life for people around the world through trusted health and nutrition solutions. "Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none," said Michael Sullivan, Senior Vice President of Product Supply for Bayer's Consumer Health division in North America. "We are excited about the positive impact this investment will have as we are paving the way for a healthier future where everyone has access to the products that they need to support their well-being." About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to View source version on Contacts Media Contact: Hannah SchwartzEmail: Cell: 862-783-8442
USA Today
14-03-2025
- Health
- USA Today
Arson investigation launched after fire at Bayer executive's New Jersey home
Arson investigation launched after fire at Bayer executive's New Jersey home Show Caption Hide Caption Health insurance industry faces backlash after UnitedHealthcare CEO death There's a common theme in the wave of unsympathetic posts about UnitedHealth exec Brian Thompson's death: rage against the health insurance industry. PARSIPPANY, N.J. — Multiple federal and state agencies are investigating a possible arson attempt at the New Jersey home of an executive of global pharmaceutical giant Bayer, authorities said. Earlier this week, the Morris County Prosecutor's Office said a fire was reported around 7:30 a.m. on March 4 at an occupied residence in the borough of Madison. The suburban community is about 15 miles west of Newark, New Jersey. The prosecutor's office told the Morristown Daily Record, part of the USA TODAY Network, that Madison firefighters responded to the incident and that the fire was quickly extinguished. No significant property damage or injuries were reported. The prosecutor's office declined to identify the residents of the home, citing an "active and ongoing" arson investigation. Bayer spokesperson Nicole Hayes confirmed to the Daily Record that an incident occurred at the "private home of one of Bayer's U.S. executives," adding that the "family is safe and unharmed." "The safety and security of our employees are of utmost importance to Bayer," Hayes said. "The incident is under active investigation. The company is cooperating fully with the investigation. We appreciate the quick response of local law enforcement." Several agencies, including the Morris County Prosecutor's Office Arson/Environmental Crimes Unit, Morris County Sheriff's Office CSI Unit, New Jersey State Fire Marshals Office K-9 Unit, New Jersey Transit Police, the Metropolitan Transportation Authority Police Department, and the New York City Police Department are investigating the incident as a possible arson. On Thursday, the prosecutor's office told NBC News and CNN that the Federal Bureau of Investigation is also assisting in the investigation. The incident was first reported by Yahoo Finance last Friday. UnitedHealth CEO: 'We understand people's frustrations' with health care system What is Bayer? Bayer, an international pharmaceutical and biotechnology company, was founded in Germany in 1863. The company initially focused on manufacturing and selling synthetic dyestuffs, according to the Bayer website. It is now one of the world's largest pharmaceutical companies and known for making prescription drugs and other consumer health products such as aspirin, Alka-Seltzer, Claritin, and Aleve. Bayer consolidated its U.S. operations in 2013, opening a new $250 million headquarters in the Whippany section of Hanover Township, New Jersey. Former New Jersey Gov. Chris Christie, who approved a $35.1 million business incentive grant to keep the company in the state, attended the grand opening. In recent years, the company has been under intense scrutiny after it acquired Roundup under the $63 billion takeover of agrochemical company Monsanto in 2018. Roundup is a popular residential and commercial herbicide widely used by landscapers and agricultural workers. Reuters reported last Friday that Bayer told U.S. lawmakers it may halt the sales of Roundup if it does not receive stronger legal protections against product liability litigation. The company has faced thousands of lawsuits that claimed victims developed a form of non-Hodgkins lymphoma from exposure to glyphosate, which was the active ingredient in Roundup sold for home use until 2023, according to Reuters. Bayer has paid about $10 billion to settle disputed claims. About 67,000 cases are pending, for which the group has set aside $5.9 billion in legal provisions. 'Root cause of health care cost': UnitedHealth CEO remembers slain colleague, talks about health care woes Incident follows increased security measures for companies Last week's incident comes amid heightened security measures and social media vitriol aimed at the health insurance industry and corporate America. Authorities and companies feared potential attacks targeting industry executives after the shooting of UnitedHealthcare CEO Brian Thompson in December. Thompson, 50, was shot outside a New York City hotel while on his way to speak at an annual investor conference. Luigi Mangione, 26, was arrested following a massive manhunt and faces state charges of murder as an act of terrorism. He pleaded not guilty in December. The shooting sparked an outpour of contempt toward health insurers with people on social media sharing their grievances over denied claims and complaints about perceived greed in the industry. In the immediate aftermath of the incident, videos posted online appeared to show "wanted" posters in New York with the names and faces of other corporate executives. Thompson's death prompted industry peers to remove biographies and photographs of top executives from their websites. Some companies also closed offices or canceled in-person events. "It was an eye-opening experience for many CEOs. ... Most of them think they're anonymous. A great deal of them, they drive themselves to work or just jump in a cab," Matthew Peters, vice president of protective services at security provider Guidepost Solutions, previously told USA TODAY. Contributing: Bailey Schulz, Ken Alltucker, Jeanine Santucci, and N'dea Yancey-Bragg, USA TODAY; Reuters
CNN
13-03-2025
- Health
- CNN
An arson investigation is underway after a Bayer executive's New Jersey home catches fire
At least eight agencies are investigating a recent fire at a Bayer executive's New Jersey home as a possible arson, authorities said. The fire happened around 7:30 a.m. March 4 'at an occupied residence on East Lane in Madison,' the Morris County Prosecutor's Office told CNN on Thursday. 'The fire was quickly extinguished by the Madison Fire Department. The structure sustained no significant damage and there were no reported injuries. The victim will not be identified.' Bayer confirmed an incident happened 'at the private home of one of Bayer's U.S. executives,' the global pharmaceutical company said in a statement to CNN. 'The family is safe and unharmed. The safety and security of our employees are of utmost importance to Bayer. The incident is under active investigation. The company is cooperating fully with the investigation. We appreciate the quick response of local law enforcement.' The prosecutor's office said the case is 'an active and ongoing arson investigation by the Morris County Prosecutor's Office Arson/Environmental Crimes Unit, Madison Police, Morris County Sheriff's Office CSI Unit, New Jersey State Fire Marshals Office K-9 Unit, NJ Transit Police, MTA Police Department, NYPD, and FBI.' The fire happened three months after United Healthcare CEO Brian Thompson was gunned down on his way to an investors' conference in Manhattan. Since then, many companies have ramped up security for their executives. Bayer, a biomedical and pharmaceutical behemoth, makes drugs such as aspirin, Claritin and Aleve. In recent years, the company has come under heightened scrutiny after it acquired agrochemical giant Monsanto in 2018. Monsanto is the maker of Roundup, a popular herbicide used by homeowners and farmers alike. Thousands of cancer patients or their estates have sued, saying Roundup gave them non-Hodgkin's lymphoma. In 2020, Bayer settled lawsuits from cancer patients in a $10 billion agreement. Bayer said the settlement agreements 'contain no admission of liability or wrongdoing.'
Yahoo
13-03-2025
- Health
- Yahoo
Arson investigation underway after a Bayer executive's home catches fire
At least eight agencies are investigating a recent fire at a Bayer executive's New Jersey home as a possible arson, authorities said. The fire happened around 7:30 a.m. March 4 'at an occupied residence on East Lane in Madison,' the Morris County Prosecutor's Office told CNN on Thursday. 'The fire was quickly extinguished by the Madison Fire Department. The structure sustained no significant damage and there were no reported injuries. The victim will not be identified.' Bayer confirmed an incident happened 'at the private home of one of Bayer's U.S. executives,' the global pharmaceutical company said in a statement to CNN. 'The family is safe and unharmed. The safety and security of our employees are of utmost importance to Bayer. The incident is under active investigation. The company is cooperating fully with the investigation. We appreciate the quick response of local law enforcement.' The prosecutor's office said the case is 'an active and ongoing arson investigation by the Morris County Prosecutor's Office Arson/Environmental Crimes Unit, Madison Police, Morris County Sheriff's Office CSI Unit, New Jersey State Fire Marshals Office K-9 Unit, NJ Transit Police, MTA Police Department, NYPD, and FBI.' The fire happened three months after United Healthcare CEO Brian Thompson was gunned down on his way to an investors' conference in Manhattan. Since then, many companies have ramped up security for their executives. Bayer, a biomedical and pharmaceutical behemoth, makes drugs such as aspirin, Claritin and Aleve. In recent years, the company has come under heightened scrutiny after it acquired agrochemical giant Monsanto in 2018. Monsanto is the maker of Roundup, a popular herbicide used by homeowners and farmers alike. Thousands of cancer patients or their estates have sued, saying Roundup gave them non-Hodgkin's lymphoma. In 2020, Bayer settled lawsuits from cancer patients in a $10 billion agreement. Bayer said the settlement agreements 'contain no admission of liability or wrongdoing.'
